We would love to hear your thoughts about our site and services, please take our survey here.
Do they need another raise before first sales to keep going ?
Trying to get a handle on the numbers HELD are targeting.
Full pelt they target 54000kg dried flowers per annum.
They have a 40,000m2 active cultivation licence, in their 195,506 square metre facility located near Thessaloniki.
Is the site with a facility set up for vertical cultivation or is it outdoor growing?
The average yield per plant is 2oz (56.7g) of bud. So the 54000kg (1,904,794ounces) per year mark looks more aspirational at this time.
They , depending on set up need 4 separate areas. Nursery stage, growing stage, flowering stage and drying area, for continual rotational cultivation. Then packing and dispatch areas on top
Ave cycle (cutting to flower) is 14 weeks. So potentially 4 crops per year. A fully grown flowering plant is easily 0.5m2 of floor space (if they’re nettles) or 1m2 if decent. Depends how crammed in they will be.
Given its medical grade there’ll be strict controls on nutrients etc.
Even if they achieve 3-4ounces per plant average under controlled growing conditions to achieve medical grade the numbers and space currently under licence are tight.
The following numbers are pretty big for the 40,000m2 licences area in my view. Unless it is set up for vertical cultivation.
80,000 plants (0.5m2) at eg. better case average of 3ounces per plant cropped and dried is 240,000ounces per crop. On a 12-14 week rotation say 4 crops per year is 960,000 ounces or 27215.5kg. So to hit their full target they need minimum 160,000 plants if they get an average of 3 ounces per plant.
More likely 1-2 ounces so more plants in my view.
The medical site (not connected to held) I have visited, used outdoor cultivation and yielded an average of 1-2 ounces of bud per plant over 16-18 week cycle. 3 crops on a 54 week cycle.
Which is why I’m asking about the numbers HELD are targeting and type of facility they have ?
New account or name change - Pump is starting.
Member since 26th Mar 2024 but already a cheerleader of Neilin.
Good luck to genuine PI holders here.
This was bid up to get the placing away. They didn’t expect the share price reaction to the placing news.
If this test works, brilliant. Lives will be saved.
Anything else is a bonus.
Green - Is the money in CIZ's bank ? Has our CEO applied for the shares to be listed ? Have the shares been issued following the application for them to be listed ?
Issuer Management team doesn't seem to have a record. Phone them and ask. See if they say the same as the person you spoke to.
At 12p before news will they raise the additional £4M needed and use FDA news to flip, or wait until FDA confirmation then raise at a higher SP to limit dilution, and announce NHS ovarian deal then US payer coverage to drive SP?
Lastly
“The Placing is not being underwritten by Allenby Capital or any other person.”
My question
“Anyone spoken to Allenby Cspital to confirm ALL their clients are happy to provide their capital ?”
If the placing had completed and the shares issued “11th April” would there have been an immediate RNS. If not would Allenby Capital be working the phones to fill any shortfall or discussing with clients the current share price in respect to placing price ?
One more thing. Where’s Neillin? Absentee silence.
Tech would you believe a poster who said yes I have or would you believe a poster who says no they phone me? Or would you believe a poster who says they’ve exchanged mobile numbers with “implied” a CEO ?
Or would you believe a poster phoning, for example, Bill in the Caymans?
Refer you to what I said previously, respectfully, DYOR. As you clearly do. Believe nothing, check everything.
Time to finish the Malbec.
The Invest: San Antonio 2023-2024 Launch Conference at the Estancia del Norte marked the official release of Capital Analytics’ 3rd edition of Invest: San Antonio, an economic report hosting top-flight industry insiders and decision-makers who discuss the key drivers impacting the present and future regional economy.
Among the various themes and topics covered during the networking and panel event were the metro area’s holistic approach to enhancing infrastructure, the critical roles of education and healthcare sectors, and San Antonio’s resilience during economic uncertainty.
Thank you to the Invest: San Antonio team and Capital Analytics for inviting the CorePath team to this event and featuring our CEO and Medical Director, Aamir Ehsan, MD on important healthcare conversations in our community. Pictured with Dr. Ehsan is Abby Melone (President & CEO of Capital Analytics), Curtis Loos (Executive V.P. of Business Operations at CorePath), and Dr. Dakota Deutsch.
Bron. 10% of nothing is nothing. Are you not concerned there has been no Result of Placing RNS ? CIZ said “ Admission will become effective and that dealings in the New Shares on the Main Market of the London Stock Exchange will commence on or around 11 April 2024.”
So if there’s no RNS on Monday 15th April at what point do you become concerned about CIZ putting in an RNS “on or around 11 April 2024.” ?
Do you think it’ll be this year for a commercially viable CIZ1b blood test for Lung cancer or next?
Jam today or jam tomorrow. Anyone spoken to Allenby Cspital to confirm ALL their clients are happy to provide their capital ?